<p>当美国近一半的公司市盈率（或称&#34;P/E&#34;）低于 16 倍时，你可能会考虑完全避免投资 <strong>艾可菲</strong>（NYSE:EFX），因为它的市盈率高达 45.7 倍。不过，仅仅根据市盈率来判断并不明智，因为可能有解释其如此高的原因。</p>
<p>我们的免费股票报告包含 1 个投资者在投资艾可菲之前应注意的警示信号。现在可以免费阅读。</p>
<p>艾可菲的盈利增长优于最近大多数其他公司，表现相对良好。似乎许多人预计强劲的盈利表现将持续，这提高了市盈率。如果不是这样，现有股东可能会对股价的可持续性感到有些紧张。</p>
<p>查看我们对艾可菲的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/175749-pe-multiple-vs-industry-1-dark/1745260734664?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/175749-pe-multiple-vs-industry-1-dark/1745260734664"/></p>
<p>NYSE:EFX 市盈率与行业比较 2025 年 4 月 21 日</p>
<p>想要了解分析师对公司的完整预估吗？那么我们的 <strong>免费</strong> 艾可菲报告将帮助你揭示未来的趋势。</p>
<h2>增长指标告诉我们关于高市盈率的什么？</h2>
<p>为了证明其市盈率的合理性，艾可菲需要实现远超市场的卓越增长。</p>
<p>回顾过去，我们看到公司去年每股收益增长了 10.0%。然而，遗憾的是，过去三年每股收益总体下降了 21%，这令人失望。因此，可以公平地说，最近的盈利增长对公司来说并不理想。</p>
<p>展望未来，分析师预计在接下来的三年中，每股收益将以每年 28% 的速度增长。这一增长预期显著高于更广泛市场的 10% 年增长预测。</p>
<p>鉴于此，艾可菲的市盈率高于大多数其他公司是可以理解的。似乎大多数投资者都在期待这种强劲的未来增长，并愿意为该股票支付更高的价格。</p>
<h2>我们可以从艾可菲的市盈率中学到什么？</h2>
<p>一般来说，我们倾向于将市盈率的使用限制在评估市场对公司整体健康状况的看法上。</p>
<p>我们已经确定，艾可菲的高市盈率是基于其预测增长高于更广泛市场的预期。目前，股东对市盈率感到满意，因为他们相当自信未来的盈利不会受到威胁。除非这些条件发生变化，否则他们将继续为股价提供强有力的支持。</p>
<p>值得注意的是，我们发现 <strong>艾可菲有 1 个警示信号</strong>，你需要考虑这一点。</p>
<p>当然，<strong>你也可能找到比艾可菲更好的股票</strong>。所以你可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司有合理的市盈率并且盈利增长强劲。</p>
<p>如果你打算交易艾可菲，可以在专业人士信任的最低成本平台 Interactive Brokers 开设账户。</p>
<p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让你可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
<p>享受无隐藏费用、无账户最低限额，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
<p>赞助内容</p>

艾可菲

<p>艾可菲公司（NYSE:EFX）的市盈率高达 45.7 倍，远高于美国平均水平 16 倍，这引发了投资者的担忧。尽管最近每股收益（EPS）增长了 10%，但该公司在过去三年中每股收益下降了 21%。分析师预测未来三年每股收益年增长率将达到 28%，这为高市盈率提供了合理性。投资者对未来收益保持信心，但存在一个警示信号。建议潜在投资者与其他市盈率合理的公司进行比较</p>

<p>When close to half the companies in the United States have price-to-earnings ratios (or &#34;P/E's&#34;) below 16x, you may consider <strong>Equifax Inc.</strong> (NYSE:EFX) as a stock to avoid entirely with its 45.7x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.</p>
<div class="lb-trans"><p>当美国近一半的公司市盈率（或称&#34;P/E&#34;）低于 16 倍时，你可能会考虑完全避免投资 <strong>艾可菲</strong>（NYSE:EFX），因为它的市盈率高达 45.7 倍。不过，仅仅根据市盈率来判断并不明智，因为可能有解释其如此高的原因。</p>
</div><p>Our free stock report includes 1 warning sign investors should be aware of before investing in Equifax. Read for free now.</p>
<div class="lb-trans"><p>我们的免费股票报告包含 1 个投资者在投资艾可菲之前应注意的警示信号。现在可以免费阅读。</p>
</div><p>With earnings growth that's superior to most other companies of late, Equifax has been doing relatively well. It seems that many are expecting the strong earnings performance to persist, which has raised the P/E. If not, then existing shareholders might be a little nervous about the viability of the share price.</p>
<div class="lb-trans"><p>艾可菲的盈利增长优于最近大多数其他公司，表现相对良好。似乎许多人预计强劲的盈利表现将持续，这提高了市盈率。如果不是这样，现有股东可能会对股价的可持续性感到有些紧张。</p>
</div><p>View our latest analysis for Equifax</p>
<div class="lb-trans"><p>查看我们对艾可菲的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/175749-pe-multiple-vs-industry-1-dark/1745260734664" alt="" original-src="https://images.simplywall.st/asset/chart/175749-pe-multiple-vs-industry-1-dark/1745260734664"/></p>
<p>NYSE:EFX Price to Earnings Ratio vs Industry April 21st 2025</p>
<div class="lb-trans"><p>NYSE:EFX 市盈率与行业比较 2025 年 4 月 21 日</p>
</div><p>Want the full picture on analyst estimates for the company? Then our <strong>free</strong> report on Equifax will help you uncover what's on the horizon.</p>
<div class="lb-trans"><p>想要了解分析师对公司的完整预估吗？那么我们的 <strong>免费</strong> 艾可菲报告将帮助你揭示未来的趋势。</p>
</div><h2>What Are Growth Metrics Telling Us About The High P/E?</h2>
<div class="lb-trans"><h2>增长指标告诉我们关于高市盈率的什么？</h2>
</div><p>In order to justify its P/E ratio, Equifax would need to produce outstanding growth well in excess of the market.</p>
<div class="lb-trans"><p>为了证明其市盈率的合理性，艾可菲需要实现远超市场的卓越增长。</p>
</div><p>Taking a look back first, we see that the company managed to grow earnings per share by a handy 10.0% last year. Still, lamentably EPS has fallen 21% in aggregate from three years ago, which is disappointing. Therefore, it's fair to say the earnings growth recently has been undesirable for the company.</p>
<div class="lb-trans"><p>回顾过去，我们看到公司去年每股收益增长了 10.0%。然而，遗憾的是，过去三年每股收益总体下降了 21%，这令人失望。因此，可以公平地说，最近的盈利增长对公司来说并不理想。</p>
</div><p>Looking ahead now, EPS is anticipated to climb by 28% per annum during the coming three years according to the analysts following the company. That's shaping up to be materially higher than the 10% per year growth forecast for the broader market.</p>
<div class="lb-trans"><p>展望未来，分析师预计在接下来的三年中，每股收益将以每年 28% 的速度增长。这一增长预期显著高于更广泛市场的 10% 年增长预测。</p>
</div><p>In light of this, it's understandable that Equifax's P/E sits above the majority of other companies. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.</p>
<div class="lb-trans"><p>鉴于此，艾可菲的市盈率高于大多数其他公司是可以理解的。似乎大多数投资者都在期待这种强劲的未来增长，并愿意为该股票支付更高的价格。</p>
</div><h2>What We Can Learn From Equifax's P/E?</h2>
<div class="lb-trans"><h2>我们可以从艾可菲的市盈率中学到什么？</h2>
</div><p>Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>一般来说，我们倾向于将市盈率的使用限制在评估市场对公司整体健康状况的看法上。</p>
</div><p>We've established that Equifax maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. Right now shareholders are comfortable with the P/E as they are quite confident future earnings aren't under threat. Unless these conditions change, they will continue to provide strong support to the share price.</p>
<div class="lb-trans"><p>我们已经确定，艾可菲的高市盈率是基于其预测增长高于更广泛市场的预期。目前，股东对市盈率感到满意，因为他们相当自信未来的盈利不会受到威胁。除非这些条件发生变化，否则他们将继续为股价提供强有力的支持。</p>
</div><p>It is also worth noting that we have found <strong>1 warning sign for Equifax</strong> that you need to take into consideration.</p>
<div class="lb-trans"><p>值得注意的是，我们发现 <strong>艾可菲有 1 个警示信号</strong>，你需要考虑这一点。</p>
</div><p>Of course, <strong>you might also be able to find a better stock than Equifax</strong>. So you may wish to see this <strong>free</strong> collection of other companies that have reasonable P/E ratios and have grown earnings strongly.</p>
<div class="lb-trans"><p>当然，<strong>你也可能找到比艾可菲更好的股票</strong>。所以你可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司有合理的市盈率并且盈利增长强劲。</p>
</div><p>If you're looking to trade Equifax, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果你打算交易艾可菲，可以在专业人士信任的最低成本平台 Interactive Brokers 开设账户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让你可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受无隐藏费用、无账户最低限额，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>赞助内容</p>
</div>

财报揭示了艾可菲公司（NYSE:EFX）的发展历程